Researchers have identified a protein which could serve as a biomarker for the early diagnosis of lung cancer.

The study, published in The American Journal of Pathology, found that high levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer than in healthy individuals.